Further research is needed to elucidate the detailed mechanisms of SFXN2’s anti-apoptotic effect and to explore whether modulating SFXN proteins could be a viable neuroprotective strategy for neurodegenerative diseases. This evidence concerns the gene SFXN2 and neurodegenerative disease.